Literature DB >> 24801909

WIP1 regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro.

Yongquan Zhang1, Hong Sun, Guangxiang He, An Liu, Fengjun Wang, Lu Wang.   

Abstract

Wild-type p53-induced phosphatase (WIP1) is overexpressed and functionally altered in multiple human malignancies. The present study investigated its abnormal expression and dysfunctions in nasopharyngeal carcinoma (NPC) in vitro. Here, analysis of WIP1 mRNA and protein in human NPC tissues revealed that both WIP1 messenger RNA (mRNA) and protein were elevated and were correlated with NPC clinical stage and metastasis in patients. In vitro experiments further showed that WIP1 inhibition led to a decrease in the proliferative ability of NPC CNE-2 and 5-8F cells accompanied by cell cycle arrest and increased apoptosis. In addition, WIP1 knockdown inhibited the invasiveness of CNE-2 and 5-8F cells and was associated with the down-regulation of the expression of matrix metallopeptidase 9 (MMP-9) mRNA and protein. Taken together, our data demonstrate that WIP1 regulates the proliferation and invasiveness of NPC cells in vitro, and this may be correlated with its modulation of MMP-9 expression, cell cycle progression and apoptosis. WIP1 functioned as a potential therapeutic target in NPC management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801909     DOI: 10.1007/s13277-014-2034-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

1.  Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents.

Authors:  Anastasia R Goloudina; Kan Tanoue; Arlette Hammann; Eric Fourmaux; Xavier Le Guezennec; Dmitry V Bulavin; Sharlyn J Mazur; Ettore Appella; Carmen Garrido; Oleg N Demidov
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Authors:  Joanne Chew; Subhra Biswas; Sathyavageeswaran Shreeram; Mahathir Humaidi; Ee Tsin Wong; Manprit Kaur Dhillion; Hsiangling Teo; Amit Hazra; Cheok Chit Fang; Eduardo López-Collazo; Dmitry V Bulavin; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2009-04-19       Impact factor: 28.824

Review 3.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

4.  E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1.

Authors:  Tzippi Hershko; Katya Korotayev; Shirley Polager; Doron Ginsberg
Journal:  J Biol Chem       Date:  2006-08-15       Impact factor: 5.157

5.  PPM1D is a potential target for 17q gain in neuroblastoma.

Authors:  Fumiko Saito-Ohara; Issei Imoto; Jun Inoue; Hajime Hosoi; Akira Nakagawara; Tohru Sugimoto; Johji Inazawa
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Dephosphorylation of γ-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control.

Authors:  Sung-Hwan Moon; Thuy-Ai Nguyen; Yolanda Darlington; Xiongbin Lu; Lawrence A Donehower
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

7.  Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.

Authors:  Zhen Liu; Lixia Li; Zhixiong Yang; Weiren Luo; Xin Li; Huiling Yang; Kaitai Yao; Bin Wu; Weiyi Fang
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

Review 8.  Regulation of the Wip1 phosphatase and its effects on the stress response.

Authors:  Julie Lowe; Hyukjin Cha; Mi-Ok Lee; Sharlyn J Mazur; Ettore Appella; Albert J Fornace
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.

Authors:  David S P Tan; Maryou B K Lambros; Sydonia Rayter; Rachael Natrajan; Radost Vatcheva; Qiong Gao; Caterina Marchiò; Felipe C Geyer; Kay Savage; Suzanne Parry; Kerry Fenwick; Narinder Tamber; Alan Mackay; Tim Dexter; Charles Jameson; W Glenn McCluggage; Alistair Williams; Ashley Graham; Dana Faratian; Mona El-Bahrawy; Adam J Paige; Hani Gabra; Martin E Gore; Marketa Zvelebil; Christopher J Lord; Stanley B Kaye; Alan Ashworth; Jorge S Reis-Filho
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

10.  A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Authors:  S Rayter; R Elliott; J Travers; M G Rowlands; T B Richardson; K Boxall; K Jones; S Linardopoulos; P Workman; W Aherne; C J Lord; A Ashworth
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  2 in total

1.  PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Authors:  Linda Zhang; Joanne I Hsu; Margaret A Goodell
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

2.  WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.

Authors:  Ya-ling Tang; Xin Liu; Shi-yu Gao; Hao Feng; Ya-ping Jiang; Sha-sha Wang; Jing Yang; Jian Jiang; Xiang-rui Ma; Ya-jie Tang; Yu Chen; Xin-hua Liang
Journal:  Oncotarget       Date:  2015-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.